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Abstract
The type III secretion system is an essential component for virulence in many Gram-negative bacteria. Though components
of the secretion system apparatus are conserved, its substrates—effector proteins—are not. We have used a novel
computational approach to confidently identify new secreted effectors by integrating protein sequence-based features,
including evolutionary measures such as the pattern of homologs in a range of other organisms, G+C content, amino acid
composition, and the N-terminal 30 residues of the protein sequence. The method was trained on known effectors from the
plant pathogen Pseudomonas syringae and validated on a set of effectors from the animal pathogen Salmonella enterica
serovar Typhimurium (S. Typhimurium) after eliminating effectors with detectable sequence similarity. We show that this
approach can predict known secreted effectors with high specificity and sensitivity. Furthermore, by considering a large set
of effectors from multiple organisms, we computationally identify a common putative secretion signal in the N-terminal 20
residues of secreted effectors. This signal can be used to discriminate 46 out of 68 total known effectors from both
organisms, suggesting that it is a real, shared signal applicable to many type III secreted effectors. We use the method to
make novel predictions of secreted effectors in S. Typhimurium, some of which have been experimentally validated. We also
apply the method to predict secreted effectors in the genetically intractable human pathogen Chlamydia trachomatis,
identifying the majority of known secreted proteins in addition to providing a number of novel predictions. This approach
provides a new way to identify secreted effectors in a broad range of pathogenic bacteria for further experimental
characterization and provides insight into the nature of the type III secretion signal.
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Introduction
Gram-negative bacteria are a major cause of many human
diseases and, due to the emergence of antibiotic resistance,
development of new means to combat their infection is a goal of
the world health organization (WHO) and other international
health organizations [1]. Pathogenic bacteria express a large
number of proteins associated with virulence some of which are
secreted into the host milieu and interfere with normal host cell
functions or immune response. Since many virulence factors allow
the survival of pathogens under very specific infectious conditions
they represent attractive targets for alternative therapies relative to
current strategies, which aim to kill all bacteria and thus efficiently
drive the emergence of antibiotic resistance and increase the host
susceptibility to other infections by eliminating the normal flora
[2].
The type III secretion system in Gram-negative bacteria forms
the interface between the pathogen and its host [3,4]. Electron
microscopy has revealed that the secretion machinery forms a
needle-like structure that spans the inner and outer bacterial
membrane [4–6] and allows injection of protein effectors directly
into the cytoplasm of the eukaryotic host cell [7]. Each bacterial
species has a repertoire of effector proteins which enact the
virulence program of the bacteria by directly interacting with host
cell pathways [7]. Though some of the genes that comprise the
secretion machinery are well-conserved between species [8,9],
sequences of virulence effectors are diverse and the identity and
nature of their signal sequences, target protein(s) in the secretion
complex, and methods of regulation are poorly understood [4].
While carboxy terminal sequences can be important, as a
general rule secreted proteins are targeted to their cognate
apparatus by a signal that is encoded in the N-terminal region
of the protein or alternatively the 59 end of the mRNA sequence,
and provides a sequence-based signature for the system [10,11].
To understand the type III secretion system and catalog its full
complement of secreted substrates it is necessary to identify this
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effectors are targeted to be secreted will provide valuable insight
into the virulence program of many Gram-negative bacteria.
Effectors generally have two N-terminal domains that are
important secretion. Residues 1–25 contain a region thought to be
a secretion signal but that is highly variable in sequence [15] and,
at least in some cases, highly tolerant of mutations [16,17]. For
some effectors this region has been shown to be both necessary and
sufficient for secretion [10,16,18,19]. However, no sequence motifs
or common patterns have been identified that can be used to
accurately predict type III secreted substrates. In addition, some
effectors contain a chaperone binding domain that spans residues
25–100 [12]. Chaperones are necessary to stabilize some effectors,
to maintain them in an unfolded state prior to secretion, and to
expose the secretion signal sequence itself [4,12]. It has been
proposed that the N-terminal secretion signal is an ‘ancestral’
flagellar targeting signal and that the chaperone-binding domain
and chaperone itself may in some cases target the effector to a
specific secretion apparatus [19].
In this study we chose to analyze type III secreted effectors and
their putative secretion signals in three organisms: S. Typhimur-
ium, P. syringae, and Chlamydia trachomatis. Though all three
organisms are Gram-negative pathogens with type III secretion
systems, they differ in host range, evolutionary history [20], and
lifestyles. Phylogenetic analyses of core components of the type III
secretion systems also suggests that though they originated from a
common ancestor, the secretion system from each of the organisms
in this study falls into a different distinct group [21,22]. Both S.
Typhimurium and P. syringae have extensively characterized
repertoires of type III secreted effectors [23,24], which provide a
sufficient number of examples for rigorous training and evaluation
of a computational learning approach such as ours. C. trachomatis
was chosen as an important pathogen, which has a relatively
poorly defined, set of secreted effectors, and thus represents a good
target for computational predictions [25].
Proteins secreted through the type III secretion system are
highly variable in sequence. Though there are related families of
effectors [26,27], a significant number have no detectable
sequence similarity to any other known effectors. Approaches
based on sequence similarity, G+C content, genomic location
within horizontally transferred regions of the chromosome,
regulation by known virulence regulators, fusion to enzymatic or
epitope tags, and homology between diverse pathogenic organisms
have all been used to identify effectors with limited success [26,28–
35]. Most recently, a proteomic approach was used to greatly
expand the estimated number of secreted effectors in pathogenic
E. coli 0157:H7 [36]. This finding indicates that there are likely to
be a large number of unknown effectors in type III secretion
system-containing bacteria, even in well-studied organisms like S.
Typhimurium and P. syringae. General features of the protein
sequence have also been used to the same end, focused on the N-
terminal secretion signal. In P. syringae the amino acid biases and
patterns in the N-terminal secretion signal were used to identify
novel effectors [30,34,37]. Detection of common promoter
elements has also been used to identify novel effectors in P.
syringae [32], but this approach is limited to known and detectable
motifs. To date there have been neither systematic predictive
studies of type III secretion system effectors nor a general strategy
to identify proteins that are targeted to the type III secretion
system.
We use a novel computational approach to identify secreted
effectors based on sequence analysis and to delineate and define a
putative N-terminal secretion signal common to the majority of
type III secreted effectors. Our method, the SVM-based
Identification and Evaluation of Virulence Effectors (SIEVE), is
trained on a set of known examples of secreted effectors based on
sequence-derived information and then used to provide accurate
predictions of secreted effectors in evolutionarily distinct bacteria.
We show that SIEVE can identify known secreted effectors very
well with simultaneous specificity and sensitivity of greater than
88% for prediction of effectors when trained on one species and
tested on the other, in the absence of detectable sequence
similarity between effectors in the two sets. A considerable
strength of our findings comes from the fact that we considered
a large number of different sequences from effectors in multiple
organisms. Previously this has only been used for detection of
sequence homology between effectors using traditional approaches
[36]. Our novel analyses allowed us to detect the presence of a
protein-encoded secretion signal in the N-terminal 16–20 residues
of the majority of type III secreted effectors examined. Though
variable in sequence, we define the most important residues for
this secretion signal across multiple organisms. Finally, we use a
model trained on the effectors from S. Typhimurium and P.
syringae to suggest new candidates for type III secretion in S.
Typhimurium and in C. trachomatis, the most common cause of
female infertility in the US [38].
Methods
Organisms Targeted and Datasets Used
We chose to target S. Typhimurium and P. syringae for our initial
analysis because they have been well studied, especially in regard
to type III secreted effectors, providing enough well-validated
examples to train and evaluate our methods. C. trachomatis was
chosen as a target for novel predictions because of the difficulties
associated with studying it experimentally and its corresponding
lack of well-validated secretion substrates.
Salmonella infection is a major public health problem with three
million cases of infection per year in the U.S. alone [39]. With the
Author Summary
Pathogenic bacteria release a number of different proteins
that function to interfere with host defenses and allow
bacterial invasion, persistence, and replication in the host.
In many bacterial pathogens, the type III secretion system
is used to inject these virulence factors directly to the
cytoplasm of the host cell. The secreted proteins do not
have well-conserved sequences and do not have any kind
of common identifiable signal sequence to target them for
secretion. This makes it very difficult to identify secreted
proteins of this kind without experimental investigation, as
can be done in other secretion systems. In this study, we
develop a computational approach to detect secreted
virulence factors from genomic protein sequences. We use
this method to compare the N-terminal regions of proteins
from S. Typhimurium and a plant pathogen, P. syringae,
and show that this approach is the most effective method
of computational identification of type III secreted proteins
to date. We further use this approach to identify a
sequence pattern in these proteins that presumably helps
direct virulence proteins to the type III secretion apparatus.
We provide novel predictions of secreted proteins in these
two organisms, as well as in the human pathogen C.
trachomatis. Better understanding of secreted virulence
factors in pathogens will lead to new ways of combating
important infectious diseases and provide understanding
of the complex interaction between pathogen and host.
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as phage type DT104 [40] the public health threat has become
greater. Genome sequences were obtained from the NCBI
database for S. Typhimurium LT2 (AE006468) and associated
virulence plasmid (AE006471). A set of 36 S. Typhimurium
proteins reported to be type III secreted effectors was compiled
from the literature (Table 1; see also [23]).
P. syringae strains have a broad host range in plants and cause a
variety of diseases and is an important model system in plant
pathology. Numerous studies of the secreted effector repertoires in
P. syringae have been published [30,32,34,37,41,42]. This makes it
an attractive model organism for testing methods to predict
secreted effectors. We used the genome sequence from NCBI for
P. syringae pathovar phaseolicola (NC_005773) and a set of 32 P.
sryingae type III secreted effectors was downloaded from the
Pseudomonas-Plant Interaction website (http://www.pseudomo-
nas-syringae.org/) hypersensitive response and pathogenicity
(Hrp) outer protein (hop) virulence protein database.
C. trachomatis is an obligate intracellular pathogen infecting
humans and causes a variety of sexually transmitted diseases [43],
as well as trachoma, a leading cause of preventable blindness
worldwide [44]. The Chlamydiae infect a wide range of
vertebrates and free-living amoebae and are a considered to be
only distantly related to the Proteobacteria [22]. Though the
genome sequence of C. trachomatis revealed the presence of a type
III secretion system [45], research on this system and its effectors
Table 1. Known secreted effectors used for training SIEVE and their scores using the STM to STM and PSY to STM SIEVE models.
ID Name Description System STMtoSTM Rank PSYtoSTM Rank
STM1055 gtgE Gifsy-2 encoded effector ??? 4.06 1 2.20 12
STM0972 sopD-2 homologous to secreted protein sopD SPI-2 3.82 2 1.80 26
STM1051 sseI/srfH Secretion system effector SPI-2 3.46 3 1.81 25
STM1583 steA putative cytoplasmic protein both 3.29 4 1.94 20
STM1088 pipB-1 Pathogenicity island encoded protein: SPI5 SPI-2 3.23 5 2.05 16
STM1631 sseJ Salmonella translocated effector SPI-2 3.11 6 1.79 27
STM2945 sopD-1 secreted protein in the Sop family SPI-1 3.09 7 1.27 33
STM1602 sifB Salmonella translocated effector SPI-2 3.06 8 1.97 19
STM4157 sseK-1 putative cytoplasmic protein SPI-2 3.05 9 1.53 31
STM2137 sseK-2 putative cytoplasmic protein SPI-2 3.01 10 2.00 17
STM1224 sifA replication in macrophages SPI-2 2.97 11 1.90 21
STM2584 gogB Gifsy-1 prophage: leucine-rich repeat both 2.86 12 1.61 29
STM2614 gogA Gifsy 1 encoded effector ??? 2.68 13 1.29 32
STM2865 avrA putative inner membrane protein SPI-1 2.66 14 1.89 23
STM2884 sipC cell invasion protein SPI-1 2.62 15 2.20 11
STM1404 sseF Secretion system effector SPI-2 2.56 16 2.61 5
STM1855 sopE-2 TypeIII-secreted protein effector SPI-1 2.49 17 1.87 24
STM2878 sptP protein tyrosine phosphate both 2.42 18 1.73 28
STM1398 sseB Secretion system effector SPI-2 2.38 19 2.06 15
STM2066 sopA Secreted effector protein SPI-1 2.37 20 2.53 6
STM1026 gtgA Gifsy 2 encoded effector ??? 2.34 21 1.60 30
STM2883 sipD cell invasion protein SPI-1 2.33 22 2.70 3
STM1393 ssaB/spiC Secretion system apparatus SPI-2 2.22 23 2.14 13
STM2868 orgC secreted repressor ??? 2.11 24 2.33 9
STM2892 invJ surface presentation of antigens SPI-1 2.03 25 2.90 2
STM1091 sopB/sigD homologous to ipgD of Shigella SPI-1 1.99 26 2.66 4
STM1400 sseC Secretion system effector SPI-2 1.94 27 3.13 1
STM1402 sseE Secretion system effector SPI-2 1.91 28 1.20 34
STM1401 sseD Secretion system effector SPI-2 1.88 29 1.98 18
STM1405 sseG Secretion system effector SPI-2 1.78 30 2.51 7
STM2780 pipB-2 homologue of pipB SPI-2 1.52 31 0.45 36
STM2882 sipA cell invasion protein SPI-1 1.40 32 2.12 14
STM0800 slrP leucine-rich repeat protein both 1.37 33 1.90 22
STM2885 sipB cell invasion protein SPI-1 1.25 34 2.32 10
PSLT039 spvB Salmonella plasmid virulence ??? 1.17 35 2.38 8
STM2241 sspH-2 Leucine-rich repeat protein SPI-2 1.11 36 1.16 35
The top 10 highest scores from the PSY to STM model are shown in bold.
doi:10.1371/journal.ppat.1000375.t001
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obligate intracellular pathogen [14]. We obtained the genome
sequence of C. trachomatis (AE001273) from the NCBI database.
SIEVE predictions for all proteins in these organisms as well as
Shigella flexneri, Yersinia pestis and Vibrio cholerae, is available as Table
S5.
Removal of Effector Homologs Identified by BLAST
To accurately determine the performance of SIEVE across
organisms, all effectors in P. syringae that had any level of sequence
similarity detectable by BLAST [46] to any effector in S.
Typhimurium were removed. This reduced the number of
effectors used in P. syringae from 32 to 29, eliminating HopAN1,
HopAJ1 and HopAJ2 from consideration. BLAST was executed
with default parameters meaning that sequence matches with
expectation values worse than 2.0 were not reported. This process
provides a conservative group of non-redundant effectors,
ensuring that the performance results we report are not based
on sequence similarity.
Machine-Learning Methodology
Support vector machines (SVM) are a class of computational
algorithms for classification [47,48]. Essentially, they can learn
patterns based on known members of a class of protein sequences
(positive examples) and the corresponding protein sequences,
which are not members of that class (negative examples). This
process is referred to as ‘‘training’’ the algorithm and results in a
computational ‘‘model’’. The model can then be used to classify a
different set of known examples to evaluate the performance of the
model or can be applied to a set of unknown sequences to provide
novel predictions. Information from each example sequence is
used to train the model and the particular types of information
chosen are referred to as the ‘‘features’’ of the model.
For training the SVM in SIEVE we chose to use known secreted
effectors as positive examples and proteins that have not been
identified as effectors, i.e. the remainder of the proteins in the
organism, as negative examples. The true set of negative examples
is actually unknown; in fact we show that a number of the proteins
in our negative example set are secreted but had not been
identified during compilation of our initial positive example set.
This fact means that the performance we report using SIEVE is a
conservative, lower bound estimate, since it contains an unknown
number of misclassified false-positive predictions (i.e. real secreted
effectors that have not yet been discovered).
Features are the different sequence characteristics used as input
to the SVM. The SVM uses the features to learn the difference
between the positive and negative examples. Five sets of features
were chosen for SIEVE based on their known or suspected
distributions in secreted effectors: evolutionary conservation of the
protein sequence (CONS), a phylogenetic profile of sequence
similarity to 54 other genomes (PHYL; Table S1), nucleotide
composition of the cognate gene (GC)[35], amino acid composi-
tion (AA)[17,41,49,50], and finally the sequence of the N-terminal
30 residues of the protein sequence (SEQ)[30,50]. To determine
the most important features for classification we used an iterative
process known as recursive feature elimination (RFE) that
successively eliminates features with low impact on the overall
performance of the model.
We used the SVM software suite Gist [51] to perform all
training, testing and evaluation of different models. Except where
noted (e.g. Figure S1), we used a radial basis function kernel with a
width of 0.5 and an optimized ratio of negative to positive
examples (Figure S2) for SIEVE classification. See Text S1 for
further details on machine-learning methods and the evaluation
approaches used.
Performance Evaluation
To evaluate the performance of the method we used measures
of sensitivity, the number of predictions that were correctly
predicted as true positives divided by the number of all positive
examples (TP/(TP+FN)), and specificity, the number of predic-
tions that were correctly predicted as true negatives divided by the
number of all negative examples (TN/(FP+TN)). We also used a
common measure of performance for classification tasks, the
receiver operating characteristic (ROC) curve that is produced by
plotting the sensitivity of the method versus specificity [52]. The
area under a ROC curve (AUC) is 1 when all examples (positive
and negative) are classified correctly and is 0.5 when classification
is random.
Results/Discussion
Existing Methods for Computational Identification of
Type III Secreted Effectors
Bioinformatics approaches have been used to identify secreted
effectors in a variety of organisms with some success [30,34,36,37].
However, the approaches described in these studies are focused on
predicting effectors in a single organism and do not generalize to
prediction in other organisms or are based on homology with
known effectors. Accordingly, we wanted to test the ability of these
methods in predicting secreted effectors in S. Typhimurium.
We first examined the ability of SecretomeP [53], a program
which identifies non-classically secreted proteins generally in Gram-
negative bacteria (http://www.cbs.dtu.dk/services/SecretomeP/).
SecretomeP identified 12 of 36 known effectors in S. Typhimurium
to be secreted, but also identified over 400 non-type III secreted
proteins, yielding an overall precision of less than 3% for type III
secreted substrates. This is not surprising since the method is trained
on proteins secreted by a number of different systems, and is not
designed to specifically identify type III secreted effectors.
We next tested the ability of two simple measures to
discriminate secreted effectors; the G+C content of the associated
gene and the number of number of polar residues [34] in the N-
terminal 30 amino acids of the protein. Plotting the sensitivity of
this method versus its specificity gives the receiver operator
characteristic (ROC) curve, which provides a summary of the
performance of a method to classify things into two categories.
Surprisingly, we found that the G+C content gave performance of
0.89 (as judged by ROC analysis) to discriminate secreted effectors
from other proteins in S. Typhimurium. However, even with this
performance the top 5 true positive predictions could be
discriminated with a precision of only about 6% (i.e. with 81 false
positive predictions) so the level of precision possible using this
measure alone was also low. Additionally, we found that G+C
content gave an ROC of 0.73 for prediction of P. syringae effectors
indicating that it cannot be used to identify all effectors with the
same confidence. The observed performance of G+C content in S.
Typhimurium may be due to the fact that most effectors are
located in horizontally transferred pathogenicity islands or islets,
such as SPI-1 and SPI-2 [54,55]. Amino acid biases were largely
uninformative for predicting effectors but the count of serine
residues in the N-terminal 100 residues gave an ROC of 0.73. This
is consistent with previous observations of amino acid biases,
including serine, in the N-terminal regions of effectors [24,41].
One previously published study that identified secreted effectors
in P. syringae based in part on bioinformatics techniques [30]
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first searching for these two motifs then applying several other
heuristic rules (e.g. sequences shorter than 150 residues were
screened out). We applied these same set of criteria to S.
Typhimurium proteins and found that they could correctly
identify only two of the known secreted effectors out of a total of
52 predictions (4% precision). This shows that these patterns while
accurate on P. syringae are not applicable to S. Typhimurium.
Another recent study used BLAST-determined sequence
similarity between secreted effectors in different organisms to
identify novel secreted effectors in Escherichia coli O157:H7 [36].
Though this approach is applicable to identification of secreted
effectors in other organisms, it is based on detectable sequence
similarity between known effectors, which is a significant
limitation. The performance of the BLAST-based approach (see
Text S1) was 0.79 for prediction of known effectors in S.
Typhimurium. Nearly one-third of the known effectors in S.
Typhimurium showed no detectable sequence similarity to any of
the effectors in the compiled list of all known effectors and thus
could not be identified by this approach.
Our results from applying these previously described methods
for identification showed that though G+C content alone was
surprisingly effective at predicting secreted effectors, its precision
was too low to provide very useful predictions. Likewise,
sequence patterns developed in P. syringae and more general
amino acid composition biases provide limited discrimination.
Finally, BLAST similarity to known secreted effectors in other
organisms provided reasonable discrimination, but this approach
identified only those secreted effectors that have been identified
in another organism.
Prediction of Type III Secreted Effectors Using SIEVE
We found that existing computational methods to identify
secreted effectors were somewhat effective in different ways when
applied to known effectors in S. typhimurium. We therefore
wanted to see if the integration of some of the data underlying
these approaches could be used for more accurate prediction of
secreted effectors. With this in mind we developed an approach to
integrate genomic sequence information using computational
techniques from data integration and machine learning techniques
(the SVM-based Identification and Evaluation of Virulence
Effectors or SIEVE). Similar methods have been used successfully
for various classification tasks using biological sequences [56–66].
These methods use a set of known training examples to classify
novel examples based on a set of features derived from the gene
and/or protein sequences. We chose to integrate several features,
using numeric values derived from analysis of the protein
sequence, that have been directly or indirectly suggested to be
important in discrimination of secreted effectors by previous
studies from a number of organisms [17,30,35,41,49,50]. These
include the G+C content (GC) and general amino acid biases (AA),
shown to have predictive value individually (see above) as well as
evolutionary relationships (EVOL and PHYL). Finally, we
included the N-terminal sequence of proteins (SEQ) to allow the
method to learn sequence patterns or biases that might be
predictive of secreted effectors. The features used by the method
are described in detail in Text S1.
To assess the ability of SIEVE to identify novel secreted
effectors we trained a SIEVE model on the set of effectors from
one organism then evaluated the methods performance on a set of
effectors from a different organism that were not used in the
training process. We examined the performance of a SIEVE
model trained on P. syringae proteins and evaluated on S.
Typhimurium proteins (PSY to STM) and the reverse experiment
of SIEVE trained on S. Typhimurium proteins and evaluated on
P. syringae proteins (STM to PSY). These results show that the
SIEVE approach performs very well at classification in terms of
both specificity and sensitivity (Figure 1). At a sensitivity of 90%,
i.e. 33 S. Typhimurium effectors and 26 P. syringae effectors, the
specificity of the method is 88% when used to predict S.
Typhimurium effectors (PSY to STM model) and 87% when
applied to P. syringae effectors (STM to PSY model). The
performance (ROC) values for classification were 0.95 and 0.96,
respectively. These results indicate that our approach to
integration of the chosen sequence-based features using a non-
linear classification method accurately predicts type III secreted
effectors between distantly related organisms. This suggests that
there may be a set of features that are shared between effectors in
both organisms, a hypothesis that we tested next.
Delineation of a Common Putative Secretion Signal
Several studies have highlighted the importance of a short
region in the N-termini of effectors in secretion [18,67,68]. This
region, thought to be between 10 and 50 amino acids in length,
has sometimes been referred to as the secretion signal, though it
does not contain any recognizable sequence pattern. Because our
models included N-terminal sequence information we wanted to
determine the length of sequence that provided the maximum
discriminatory power for classification. We therefore examined
the effect of including sequences of different lengths in both
models to provide accurate discrimination of effectors. We
trained models with the other types of features (EVOL, GC, AA
and PHYL) using the N-terminal 0 to 40 residues as the SEQ
feature set. A total of 10 models for each sequence length were
trained using randomly selected negative examples and the mean
performance (i.e. ROC) was calculated. The results for the S.
Typhimurium signal (PSY to STM model) and the P. syringae
signal (STM to PSY model) are shown in Figure 2A. Both models
show an increase in performance from the baseline value (which
includes no SEQ features) reaching a maximum when the length
of the sequence reaches 29 or 31 amino acid residues,
respectively. Additional sequence information beyond this length
does not improve the ability of the model to classify effectors in
the opposite organism.
We next determined the sequence length that provides the
majority of the information for each model, i.e. what is the length
of sequence beyond which adding more residues to the model fails
to improve performance significantly? This analysis is shown in
Figure 2B and was performed by calculating the difference in
performance between the maximum performance for that model
and performance for each sequence length and dividing this
number by the standard error for that performance. In this
analysis values that are less than 2.0 represent insignificant
differences, for which the standard error would begin to overlap
from the two values. According to the plot in Figure 2B the
maximum significant length for the N-terminal sequence was
determined to be 21 and 16 for S. Typhimurium (PSY to STM
model) and P. syringae (STM to PSY model) effectors, respectively.
These lengths agree generally with previously determined
estimates of the length of the secretion signal
[4,12,16,18,24,67,68] and indicate that a significant amount of
information is shared between effectors across organisms in their
N-terminal 30 residues, with most of the information residing in
the first 16–20 residues. These results further support the
hypothesis that there is a significant, sequence-based secretion
signal in the N-termini of effectors which is not possible to detect
using traditional alignment methods such as BLAST.
Prediction of Type III Effectors
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Based on the success of our models at accurately identifying
secreted effectors from sequence information we examined the
hypothesis that this region contains a hidden sequence motif,
possibly derived from an ancient ancestor [19]. To determine the
most important sequence-derived features for the classification task
in each of the models we used a recursive feature elimination
approach (see Text S1 for details). We found that a minimal set of
88 (out of a total of 711) features retained the ability to accurately
classify secreted effectors (Figure S4). The features that are most
important for accurate classification include the evolutionary
conservation feature (CONS) and G+C content (GC), as well as
several phylogenetic profile (PHYL) features (see Text S1) and a
number of specific sequence biases that span the 30 residue
putative secretion signal discussed below.
The models both contained a set of significantly important
residues. These residues, shown in Figure 3, represent those
positions and residue types that the models found to be most
important for classification. They form two weak sequence motifs,
which are detectable by SIEVE in comparison to the background
the N-terminal sequences from all other non-secreted proteins in
the organism. The most significant sequence features that are
shared between the two models are also shown in Figure 3 with a
grey background. This indicates that the secretion signal from
both organisms are more likely to have an isoleucine at position 3,
an asparagine at position 5, a serine or glycine at position 8, and a
serine at position 9, in addition to several other shared biases. The
concentration of shared important features in the N-terminal 10
residues agrees with results from the sequence length analysis
(Figure 2) showing that the greatest gains in classification
performance are from this region.
The sequence motifs obtained here are consistent with a
number of previous observations. They are rich in polar residues,
especially serines, and have few charged residues, as observed in P.
syringae [24,41]. The sequence patterns previously derived from P.
syringae effectors [30] are almost completely consistent with the
sequence biases from our models. Though, as we showed, these
patterns are ineffective at accurately discriminating effectors in S.
Typhimurium. Finally, it was shown that all proteins bearing
synthetic secretion signals with the pattern MxIISSxS, among
others, were highly secreted in Yersinia pestis [17], which agrees well
with the pattern identified for S. Typhimurium.
Our results support the existence of a conserved, though highly
variable, secretion signal encoded in the N-terminal 16–20
residues of type III secreted effectors. The important residues do
not form a classic sequence motif but rather can be thought of as
significant residue tendencies of the secretion signal. This type of
secretion signal has been found in other secretion systems, most
notably the Sec system in bacteria [69]. In the Sec system no
Figure 1. Accurate identification of type III secreted effectors using sequence data. The sensitivity (TP/(TP+FN); solid lines) and specificity
(TN/(FP+TN); dashed lines) of SIEVE on S. Typhimurium predictions (PSY to STM model; red) and P. syringae (STM to PSY model; blue) effectors were
calculated as a function of a SIEVE score threshold (X axis). The results show that both models perform well providing a maximum sensitivity and
specificity at about 90%. For example 33 of 36 known S. Typhimurium effectors are in the top 10% of predictions.
doi:10.1371/journal.ppat.1000375.g001
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residues and a hydrophobic domain allows accurate detection of
secreted substrates [70]. Collectively these results represent a large
number of hypotheses that can be tested, for instance using
mutagenesis and secretion assays, that will further elucidate the
nature of the secretion signal and can help refine the models
presented here. The lack of a classical sequence motif for secretion
is expected from the historical failure of traditional sequence motif
identification methods to identify type III secretion signals. It may
also partly explain the observation that the N-terminal sequence
shows considerable plasticity and yet can be functional [4,16]. We
provide the unaligned N-terminal sequences of the effectors used
in this study and show their agreement with the sequence
tendencies presented in Figure 3 as Table S4.
Identification of Novel Putative Type III Secreted Effectors
in S. Typhimurium
We next wanted to test if SIEVE could generate useful
predictions of novel type III secreted effectors in a well-
characterized bacteria. Accordingly, we generated a ranked list
of predictions by combining results from two applicable models
(PSY to STM and STM to STM, see Text S1) in S. Typhimurium.
We show a selection of the highest scoring ,2% of the predictions
in Table 2, and the remainder of these predictions are available as
Table S2. To help biologists interpret the scores associated with
each prediction we calculated a confidence range for novel
predictions based on a conservative set of positive and negative
examples (those described here) and a ‘‘generous’’ set. The
generous set uses a set of negative examples that limited to those
proteins with well-defined functions. This process is described in
Text S1 (Figure S3) and is used to provide useful hypotheses for
experimental validation.
Investigating the proteins in Table 2, we found evidence that the
SIEVE predictions identify proteins that are likely to be secreted.
The SIEVE results for S. Typhimurium contain two highly
confident predictions (SpvD and SpvC), which are in an operon
that is co-regulated with SPI-2 and contains SpvB, which is a
known effector. Though SpvC was not included in our positive
example set a recent publication has identified it as being a
secreted effector [71]. Although there was evidence that SpvD was
secreted into the supernatant [72], these results did not show that
it was a type III secreted effector and so SpvD was also not
included in our positive example set. SpvD is the prediction with
the highest score providing further evidence that it is a secreted
effector. The prediction list also includes three proteins for which
the cognate gene is regulated by the PhoP/Q two-component
regulatory system [73–75], envF and pagDK. PhoP/Q is induced
in acidic and Mg2+-poor medium and within the macrophage
phagosome [76–78]. We used a CyaA fusion assay to show that
PagD is secreted in macrophages (L. Crosa and F.H. unpublished
results), further validating that the approach is useful for predicting
secreted effectors. Finally, the ZirS protein was identified by
SIEVE. Interestingly, this protein was recently found to be the
secreted protein from a novel two-partner secretion system, ZirTS
[79]. Though ZirS is thought to have a cleaved signal peptide
directing it through the inner membrane our findings suggest that
the targeting signal for ZirS may be similar to that of the type III
secretion system. In total, four of our novel predictions have been
shown to be secreted experimentally. We are currently validating
other predictions.
Since many of our novel predictions do not have functional
annotations and have not been experimentally investigated
individually, we assessed the general role of proteins predicted to
be secreted by SIEVE in virulence by one or more negative
Figure 3. Identification of a shared sequence motif in type III secreted effectors. We identified the features (sequence locations and residue
types) with the greatest ability to classify S. Typhimurium and P. syringae secreted effectors (see text and Figure S4). The residue type with the highest
positive weight is shown in bold for each position, followed by the other residue types that were also found to be significant. Amino acids with a
negative weight are also shown. Positions with an ‘‘x’’ have no representation in the minimal set. Grey background indicates sequence positions
where both models agree (for at least one amino acid type). It is important to note that this does not represent a consensus sequence, since there is
very little similarity between individual effector signals (see Table S4). Rather it shows those sequence positions and amino acid types that SIEVE
found particularly helpful in discriminating between the secreted effectors and negative examples.
doi:10.1371/journal.ppat.1000375.g003
Figure 2. Delineating the length of the type III secretion signal. A. The performance of SIEVE on S. Typhimurium (PSY to STM model; red) and
P. syringae (STM to PSY model; blue) was evaluated using the ROC area under the curve metric described in the text (Y axes). Models were trained
using the indicated number of residues from the N-termini of the examples (X axis) and tested on the complete testing set (i.e. the entire set of
positive and negative examples from the other organism). Maximum performance of both models was at approximately 30 residues (asterisks)
suggesting that this might be the maximum length of a secretion signal. B. From the analysis in panel A we calculated the difference from the
maximum ROC value (at 29 for the PSY to STM model and 32 for the STM to PSY model) for each length sequence and divided this by the standard
error (difference from maximum, Y axis) for that sequence length (X axis). This shows the significance of each sequence length, with values below 2.0
(grey area) having insignificant differences (as judged using standard error). For S. Typhimurium effectors (PSY to STM model) the longest sequence
length that is significantly different from the maximum value is 21 residues and for the P. syringae effectors (STM to PSY model) it is 16 residues. These
lengths agree generally with previous estimates of secretion signal length.
doi:10.1371/journal.ppat.1000375.g002
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vivo [80–83]. From this analysis we found a greater than 2-fold
enrichment of predictions implicated in one or more negative
selection study in the predictions with scores in the top 10%
relative to those in the remaining 90% (p value 1e-28; using a two-
tailed Student’s t-test). It is important to note that many of the
known S. Typhimurium effectors (10 of 37) were not identified in
any of the original negative selection experiments most likely due
to functional redundancy as well as specifics of the virulence assay
employed in terms of different hosts and/or cell types. So the fact
that some of our predictions are not found on these lists does not
mean that they are not important in virulence. Rather, predictions
that are known to be essential in virulence represent high-priority
targets for future investigation.
Two classes of genes identified appear to be false positive
predictions. Several components involved in the biosynthesis of
lipopolysaccharide (LPS) and O-antigen are identified by SIEVE.
Since the complex directing biosynthesis and transport of LPS
occurs at the inner membrane [84], it is possible that components
of this system use a targeting signal that is similar to type III
secreted effectors. Several plasmid-encoded conjugative transfer
proteins are also identified by SIEVE; TraJ, TraM, and TraS. The
Table 2. High confidence secreted effector predictions in S. Typhimurium.




3 spvD Salmonella plasmid virulence: hydrophilic protein 3.48 100% [72]
PSLT038
3 spvC Salmonella plasmid virulence: hydrophilic protein 2.35 70% [71,80]
STM1417 ssaP Secretion system apparatus 2.97 100% [81,83]
STM2897 invE invasion protein 2.60 85% [80–82]
PSLT073 traM conjugative transfer: mating signal 2.38 70%
PSLT075 traJ conjugative transfer: regulation 2.43 75%
PSLT102 traS conjugative transfer: surface exclusion 2.21 60%
STM2087 rfbV LPS side chain defect: abequosyltransferase 2.60 85% [80]
STM2088 rfbX LPS side chain defect: putative O-antigen transferase 2.38 70% [80,81]
STM1332 rfc O-antigen polymerase 2.70 90%
STM2112 wcaD putative colanic acid polymerase 2.21 60%
STM1244
3,4 pagD PhoP regulated 2.08 50% [81]
STM1867 pagK PhoPQ-activated gene 2.47 75% [81]
STM1240 envF putative envelope lipoprotein 2.41 75% [81]
STM2866 sprB transcriptional regulator 2.16 55%
STM1087 pipA Pathogenicity island encoded protein: SPI3 2.30 70%
STM1381 orf245 putative cytoplasmic protein 2.32 70% [80,81]
STM1896 putative cytoplasmic protein 2.19 55% [80,81]
STM2761 putative inner membrane protein 3.00 100% [82]
STM1668
3,5 zirS putative outer membrane or exported 2.57 85% [79,82]
STM4302 putative cytoplasmic protein 2.41 75% [82]
STM4316 putative cytoplasmic protein 2.34 70% [82]
STM1228 putative periplasmic protein 2.33 70% [82]
STM3026 putative outer membrane protein 2.14 55% [82]
STM2138 putative cytoplasmic protein 2.71 90% [81]
STM2585A Gifsy-1 prophage: similar to transpose 2.58 85% [81]
STM4257 putative inner membrane or exported 2.49 80% [81]
STM0284 putative shiga-like toxin A subunit 2.44 75% [81]
STM2225 putative inner membrane protein 2.26 65% [81]
STM1868A putative protein 2.19 55% [81]
STM1554 putative coiled-coil protein 2.59 85% [80]
STM0100 putative cytoplasmic protein 2.54 80% [80]
STM4155 putative inner membrane protein 2.39 70% [80]
STM2208 putative inner membrane protein 2.35 75% [80]
STM3052 putative outer membrane protein 2.28 65% [80]
1confidence based on the ‘‘generous’’ estimate in Figure S3.
2references for secretion or involvement in virulence.
3proteins experimentally determined to be secreted.
4L. Crosa and F.H., unpublished results.
5not secreted by a type III secretion system.
doi:10.1371/journal.ppat.1000375.t002
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during mating pair formation [85]. The TraM and TraJ proteins
are associated with the relaxosome [86], the protein complex that
binds DNA and readies it for transport through the associated type
IV secretion system [85] and TraS is an outer membrane protein
involved in the entry exclusion (Eex) system. It is possible that
components of the type IV secretion system may share some
similarity with the type III system that allows them to be identified
by SIEVE.
SIEVE predicted components from three different functional
groups to contain secretion signals, type III secretion system
substrates, type IV secretion system-associated complexes and LPS
biosynthesis proteins. Each of these are targeted to the cytoplasmic
face of the inner membrane, either to be secreted or to form a
functional complex. Our findings imply that diverse mechanisms
of membrane targeting may share common features that direct
targeting. Though they have different mechanisms, the types III
and IV secretion systems share the common function of
transporting virulence factors into host cells. The similarity
between these two systems is supported by the observation that
some type IV secreted effectors in Legionella pneumophila can be
identified using SIEVE trained on type III secreted effectors from
S. Typhimurium (J.M. unpublished results).
As can be seen in Table 2, a number of other interesting
predictions are made by SIEVE. However, the value of the SIEVE
approach is demonstrated in that 74 of the predictions (82%) have
unknown or poorly described functions. Of these proteins 19 have
been implicated in virulence by at least one of the negative
selection studies, providing a reasonable starting point for
experimental investigation.
Identification of Novel Putative Type III Secreted Effectors
in C. trachomatis
Finally, we examined the ability of SIEVE to provide useful
predictions of type III secreted effectors for an organism that is
difficult to study. We trained SIEVE on the positive and negative
examples from both S. Typhimurium and P. syringae and applied
the model to the C. trachomatis genome. Examining the list of top
10% of predictions (Table 3) from C. trachomatis showed that a
number of these proteins have been demonstrated to be secreted
(bold type) by various experimental methods or predicted to be
secreted by other computational approaches.
Because it is complicated to work with both in terms of culturing
and genetic manipulation [14,22], a number of studies have been
performed to identify candidate effectors by expression in
heterologous systems or in cell culture systems [87–90]. Several
of these studies have identified candidate effectors by their
localization in the host cell [90–92]. During infection Chlamydia
resides in a specialized cytoplasmic vacuole, also called an
inclusion. Thus proteins that are localized to the inclusion body
membrane, as well as those that are present in the cytoplasm are
thought to be secreted through the type III secretion system. A
recent study investigated 50 Chlamydial proteins believed to be
localized to the inclusion membrane based on previous experi-
mental or predictive studies [90]. Twenty-two of these proteins
were determined to be inclusion localized, and 12 of these appear
on our high-confidence list. Also, none of the 7 proteins found to
be not secreted by this study were predicted by SIEVE. A family of
several phospholipase D-like proteins predicted by SIEVE have
also been implicated in pathogenesis, though have not been shown
to be secreted and/or localized to the inclusion body [93]. Finally,
two polymorphic membrane protein (Pmp)-like proteins, Pls1 and
Pls2, were found to be localized to the inclusion membrane [92].
However, their secretion was not blocked by a type III secretion
system inhibitor, suggesting that they are secreted by a novel
mechanism. Our findings suggest that, similar to the ZirS protein
identified in S. Typhimurium, the secretion signals for Pls1 and
Pls2 are related to the type III secretion signal.
A number of other proteins on our list were shown to be
secreted by heterologous expression systems. One large scale study
in Shigella flexneri [89] used a reporter system to identify 18
candidate secreted substrates, 7 of which are on our high
confidence list. Other experiments identified TARP (CT456)
[94] and CT847 [95] as secreted proteins, also showing that they
were localized to the host cell during infection. Finally, our
confident predictions include 8 proteins predicted to be secreted
by a previous computational analysis [25], but not yet experi-
mentally validated. Again, a large number of the predictions are
hypothetical proteins with no annotation providing a specific and
confident set of candidates for further study.
We also examined the known or predicted effectors that were
not in the top 10% of predictions (Table S3). These included 21
proteins known to be secreted, but eight of these (including IncA)
were in the top 30% of SIEVE predictions. It is important to note
that some of the experimental methods used to identify secreted
proteins, such as secretion in a heterologous system [89], are
merely suggestive that the protein is secreted C. trachomatis.
Therefore this list is likely to be both incomplete and contain a
number of false positives.
In total, 24 of the 86 top SIEVE predictions (28%) are known
secreted effectors, have been shown to be localized to the inclusion
membrane or cytoplasm of the host, or have been shown to be
secreted in a heterologous expression system. This is in contrast to
the 21 of 788 (3%) of these proteins in the remaining 90% of the
genome. We determined the performance of the method in C.
trachomatis as 0.89, though this is a conservative estimate of since it
is likely that this list is incomplete and may contain false positives.
These results show that our method, trained on proteins from
other organisms, can provide useful predictions for other bacteria.
Conclusions
Identification of the secretion signal that allows proteins to be
targeted for secretion is of paramount importance for understand-
ing any secretion system [69]. The type III secretion system is
essential for virulence in a number of pathogenic bacteria and has
been well studied in terms of its regulation, structural organization
and secreted substrates [4,8,9,12]. Despite extensive investigation
the nature and even existence of a secretion signal for substrates of
the type III secretion system remains a debated topic [4]. Though
the N-terminal region of a number of substrates has been shown to
be necessary and, in some cases, sufficient, for secretion [16,18],
there is no clear sequence motif that is common to substrates, even
those from the same bacteria. Several alternative hypotheses have
been presented to explain this observation: that a cryptic amino
acid sequence serves as the signal by adopting an unstructured or
flexibly structured conformation; that the secretion signal is
encoded by the mRNA and is not directly dependent on the
protein sequence; or that targeting is accomplished by chaperone
proteins that specifically bind the substrates [4]. There is evidence
for each of these hypotheses indicating that targeting may be a
complex and multifaceted process. Using an in silico approach, we
provide evidence that the protein sequence in the N-terminal 30
residues of the majority of known substrates from two bacteria
provides enough information to allow accurate classification by a
machine-learning algorithm. We also show that there are
significant sequence biases in this region, some of which are
shared between organisms, but these are not identifiable by
traditional sequence analysis methods. These findings indicate that
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ID Name Description Score Confidence
1 Reference
CT006 - hypothetical protein 1.32 20% [25,90]
CT007 - hypothetical protein 1.41 25%
CT011 - hypothetical protein 1.63 40%
CT049 pls1 hypothetical protein 1.89 40% [92]
CT050 pls2 hypothetical protein 2.26 65% [90,92]
CT060 flhA Flagellar Secretion Protein 1.59 30%
CT080 ltuB hypothetical protein 1.90 50%
CT082 - hypothetical protein 2.57 80%
CT087 malQ 4-alpha glucanotransferase 2.10 50%
CT088 sycE Secretion Chaperone 1.93 50%
CT089 lcrE/copN Low Calcium Response E 1.75 40% [90,91,105]
CT101 - hypothetical protein 1.40 25% [25]
CT105 - hypothetical protein 3.43 100%
CT118 - hypothetical protein 1.38 20% [90]
CT142 - hypothetical protein 1.36 20%
CT147 - hypothetical protein 1.80 40% [90]
CT148 mhpA Monooxygenase 1.41 25%
CT154 - Phospholipase D Endonuclease 2.10 50% [93]
CT155 - Phospholipase D Endonuclease 1.53 30% [93]
CT157 - Phospholipase D Endonuclease 2.42 75% [93]
CT164 - hypothetical protein 2.18 60% [25,90]
CT165 - hypothetical protein 1.67 40%
CT166 - hypothetical protein 1.91 50%
CT174 - hypothetical protein 1.30 20%
CT181 - hypothetical protein 2.40 70%
CT196 - hypothetical protein 1.55 30% [25,90]
CT198 oppA_3 Oligopeptide Binding Protein 1.33 20%
CT205 pfkA_1 Fructose-6-P Phosphotransferase 1.44 25%
CT214 - hypothetical protein 1.44 25% [90]
CT223 - hypothetical protein 1.40 25% [25,90]
CT228 - hypothetical protein 2.61 85% [25,90]
CT229 - hypothetical protein 1.96 50% [25,90]
CT232 incB Inclusion Membrane Protein B 1.45 25% [25,90,105]
CT233 incC Inclusion Membrane Protein C 2.38 70% [25,90,105]
CT262 - hypothetical protein 1.37 20%
CT273 - hypothetical protein 1.33 20%
CT288 - hypothetical protein 1.38 20%
CT309 - hypothetical protein 1.35 20%
CT311 - hypothetical protein 1.63 40%
CT326 - hypothetical protein 2.46 75%
CT344 lon Lon ATP-dependent protease 1.72 40%
CT345 - hypothetical protein 1.81 40% [25,90]
CT358 - hypothetical protein 2.03 50% [25,90]
CT365 - hypothetical protein 2.44 75% [90]
CT384 - hypothetical protein 1.78 40%
CT391 - hypothetical protein 1.31 20%
CT392 yprS hypothetical protein 2.36 70%
CT412 pmpA Putative outer memb. protein A 1.97 50%
CT440 - hypothetical protein 1.68 40% [25,90]
CT449 - hypothetical protein 1.78 40% [25,90]
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type III secreted substrates and provide a number of testable
hypotheses regarding this putative signal. Our results do not
disprove the alternatives (that the signal is encoded by mRNA or
resides on the chaperones) but indicate that a majority of the
secreted substrates from S. Typhimurium and P. syringae have a
protein-encoded, N-terminal secretion signal.
Most of the core components of the type III secretion system are
conserved between species [22,96] and several lines of evidence
indicate that the targeting mechanisms employed by the system
may also be conserved. The first is that type III secretion systems
can export proteins encoding secretion signals from other bacteria
[97–99]. The second is that a recently discovered class of type III
secretion inhibitor can block secretion in Y. pestis, C. trachomatis and
S. Typhimurium [2,100–103], though the mechanism of inhibition
is unclear [103]. Finally, it has been shown from available
structures of effectors bound to their cognate chaperones that the
structure of this interaction is conserved across species [104].
These observations have important implications for development
of new antibacterial agents. Our findings support a model of the
type III secretion process that includes a targeting mechanism that
is conserved between organisms. Despite our identification of some
generally conserved features between the two targeting signals the
lack of a well-defined targeting sequence leaves open the questions
of what features of the secretion signal are recognized by the
targeting system. The importance of particular residues as
determined by our analysis suggests that there are underlying
conserved structural requirements which form the basis for
ID Name Description Score Confidence
1 Reference
CT456 TARP hypothetical protein 2.81 90% [94]
CT461 yaeI Phosphohydrolase 1.69 40%
CT483 - hypothetical protein 2.12 55% [25,90]
CT529 - hypothetical protein 1.53 30% [89,90]
CT552 - hypothetical protein 1.40 25%
CT559 yscJ Yop proteins translocation 1.35 20%
CT578 - hypothetical protein 3.31 100% [89]
CT583 gp6D CHLTR Plasmid Paralog 1.81 40%
CT616 - hypothetical protein 2.19 55%
CT620 - hypothetical protein 1.97 50%
CT622 - CHLPN 76 kDa Homolog 1.92 50%
CT623 - CHLPN 76 kDa Homolog 1.69 40%
CT642 - hypothetical protein 1.43 25% [89]
CT664 - adenylate cyclase-like protein 1.35 20%
CT668 - hypothetical protein 1.37 20%
CT671 - hypothetical protein 1.76 40% [89]
CT672 fliN Flagellar Motor Switch 1.74 40%
CT694 - hypothetical protein 3.52 100%
CT695 - hypothetical protein 2.28 65%
CT696 - hypothetical protein 1.38 20%
CT711 - hypothetical protein 1.98 50%
CT718 - hypothetical protein 2.16 55% [89]
CT728 - hypothetical protein 1.36 20% [25,90]
CT736 ybcL hypothetical protein 2.75 90%
CT794.1 - hypothetical protein 1.50 30%
CT795 - hypothetical protein 1.96 50%
CT809 - hypothetical protein 1.79 40%
CT847 - hypothetical protein 2.21 60% [95]
CT849 - hypothetical protein 1.93 50%
CT853 - hypothetical protein 1.32 20%
CT860 - hypothetical protein 1.92 50% [89]
CT863 - hypothetical protein 1.59 40% [89]
CT867 - Membrane Thiol Protease 3.02 100%
CT868 - Membrane Thiol Protease 4.17 100%
CT870 pmpF Putative Outer Membrane Protein 1.65 40%
CT872 pmpH Putative Outer Membrane Protein 1.33 20%
1confidence based on the ‘‘generous’’ estimate in Figure S3.
Bold type indicates that the protein has been shown to be secreted in one of several experimental systems.
doi:10.1371/journal.ppat.1000375.t003
Table 3. Cont.
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large range of different sequences.
The results we have presented show only that there is a
significant amount of shared information between secreted
effectors, especially in the N-terminal sequences. We propose that
this shared information represents a biological function, that of
type III secretion, and that the sequence patterns identified are
functionally important in terms of targeting the proteins to the
secretion apparatus. Further experimental investigation, for
example mutational analyses based on these predictions, is
necessary to validate this hypothesis. Also, we have presented a
large number of high-confidence predictions of novel secreted
effectors, a number of which have experimental evidence strongly
suggesting that they are secreted substrates. Again, further
experimental investigation of these predictions will allow refine-
ment of the approaches described.
The results presented here support previous findings that
diverse bacteria have similar type III secretion system targeting
signals [97–99]. We have described a novel computational method
for data integration and classification to discriminate secreted
effectors from the type III secretion system in two evolutionarily
distinct organisms. The excellent performance of this method on
discrimination of secreted effectors shows that the groups of
effectors from the two organisms are similar based on a number of
sequence-derived characteristics, despite the lack of detectable
sequence similarity between them. Using the models produced by
SIEVE we identified a set of conserved sequence biases that define
a putative, common secretion signal for type III secreted effectors.
This approach is a novel and effective way to identify secreted
effectors in a broad range of pathogenic bacteria and provides
valuable insight into the nature of the type III secretion signal.
Supporting Information
Figure S1 Performance of SIEVE models using different SVM
kernel functions and parameters. The performance of the PSY to
STM (red) and STM to PSY (blue) models were evaluated using
the ROC area under the curve metric described in the text (Y
axis). Performance using the radial basis function (radial) with a
width parameter of 0.5 provided the best results for both models.
Found at: doi:10.1371/journal.ppat.1000375.s001 (0.20 MB TIF)
Figure S2 SIEVE performance using different ratios of negative
top positive examples in the training process. The performance of
the PSY to STM (red) and STM to PSY (blue) models were
evaluated using the ROC area under the curve metric described in
the text (Y axis). Models were trained with the radial basis function
kernel and a width of 0.5 (see Figure S1) using the indicated ratio
of negative to positive examples (X axis) and tested on the
complete testing set (i.e. the entire set of positive and negative
examples from the other organism). ‘Natural’ indicates that the
entire set of negatives (all the proteins in the organism) were used
for training. Error bars indicate +/21 standard error calculated
from 10 training runs using random selections of negative
examples. The best performance is obtained using ratios of 20:1
and 60:1 for the STM to PSY and PSY to STM models,
respectively. For consistency the ratio of 20:1 was chosen for
further SIEVE training in both models since it gives the best
performance for the PSY to STM model and reasonable
performance for the STM to PSY model.
Found at: doi:10.1371/journal.ppat.1000375.s002 (0.17 MB TIF)
Figure S3 Estimation of SIEVE Prediction Confidence. A. The
positive predictive value, the number of true positive predictions
divided by the total number of predictions made at a particular
score threshold (TP/(TP+FP)) is shown (Y axis) plotted against the
SIEVE score threshold (X axis) for the conservative evaluation set,
all proteins not experimentally determined to be secreted effectors
are treated as negatives (green line), and the generous evaluation
set, only proteins with known functions are considered as negative
examples (black line). B. The number of false positive predictions
(green; with known functions), novel predictions (grey; with no
known function) and known secreted effectors (blue) are shown at
several different confidence thresholds (as determined from the
generous evaluation set).
Found at: doi:10.1371/journal.ppat.1000375.s003 (3.00 MB TIF)
Figure S4 A minimal set of sequence-based features for accurate
discrimination of type III secreted effectors. A recursive feature
elimination approach was used that successively eliminates the
50% of the features in the SVM model which have the least
impact on the ability to discriminate between the positive and
negative examples. Shown are the ROC area under the curve
values averaged from 10 independent feature elimination runs (Y
axis) for each step in the process (X axis, showing the number of
remaining features in the models). Error bars indicate +/21
standard error. A significant drop in performance is observed
when the number of features drops below 88. The identities of the
conserved minimal feature set are shown in Figure 3 and
implications discussed in the main text.
Found at: doi:10.1371/journal.ppat.1000375.s004 (0.15 MB TIF)
Table S1 List of organisms used in the phylogenetic profile input
to SIEVE.
Found at: doi:10.1371/journal.ppat.1000375.s005 (0.04 MB XLS)
Table S2 Additional high-confidence Predictions in S. Typhi-
murium.
Found at: doi:10.1371/journal.ppat.1000375.s006 (0.04 MB XLS)
Table S3 Known or predicted secreted proteins in C. trachomatis
not highly predicted by SIEVE.
Found at: doi:10.1371/journal.ppat.1000375.s007 (0.04 MB XLS)
Table S4 Unaligned N-terminal Sequences of Secreted Effectors
and Agreement with SIEVE Positional Biases.
Found at: doi:10.1371/journal.ppat.1000375.s008 (0.04 MB XLS)
Table S5 Complete geneome SIEVE predictions for S. Typhi-
murium, P. syringae, C. trachomatis, S. flexneri, V. cholerae, and Y. pestis.
Found at: doi:10.1371/journal.ppat.1000375.s009 (4.15 MB XLS)
Text S1 Supplemental Methods and Information. In this section
we present a complete and detailed description of the computa-
tional methods underlying the analysis described in the main text.
We also include a number of results that support the main analysis
including optimization of parameters for SIEVE, determination of
confidence bounds for SIEVE predictions and several peripheral
experiments designed to address the hypotheses presented in the
main text.
Found at: doi:10.1371/journal.ppat.1000375.s010 (0.40 MB
DOC)
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